EGF 抗体 (AA 609-751)
Our Local Distributor
北京 101111
Quick Overview for EGF 抗体 (AA 609-751) (ABIN7616677)
抗原
See all EGF 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 609-751
-
原理
- Epidermal Growth Factor (EGF) Polyclonal Antibody
-
序列
- Ala609~Gly751
-
产品特性
- The Epidermal Growth Factor (EGF) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
-
纯化方法
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.54 mg/mL
-
缓冲液
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
- EGF (Epidermal Growth Factor (EGF))
-
别名
- EGF
-
基因ID
- 1950
-
UniProt
- P01133
-
途径
- NF-kappaB Signaling, RTK signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
抗原
-